Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
Murphy
G
G
Coughlan
R
R
Devlin
J
J
FitzGerald
O
O
McCarthy
G
G
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001691:Biological Therapy; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D019990:Perioperative Care
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate